Patents by Inventor Chantal Proulx

Chantal Proulx has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7452662
    Abstract: Based on previous evidence suggesting positive effects of fever on in vivo hematopoiesis, the effect of hyperthermia on the expansion and differentiation of megakaryocytes (MKs) in ex vivo cultures of CB CD34-enriched cells has now been tested. Cells were cultured at 37° C. or 39° C. for 14 days in cytokine conditions optimized for MK development, and analyzed periodically by microscopy, flow cytometry and colony assays. Compared to 37° C., cultures maintained at 39° C. produced much more total cells (5×), MK progenitors (9×) and total MKs (7×), and showed accelerated (3-4 days) and enhanced MK maturation with increased yields of proplatelets and platelets (11.7×). The increased number of CD34+ cells and myeloid progenitors in the 39° C. cultures also suggested a general stimulatory effect of hyperthermia on the expansion of more primitive stem/progenitor cells and of cells of other lineages.
    Type: Grant
    Filed: April 25, 2005
    Date of Patent: November 18, 2008
    Assignee: Hema-Quebec
    Inventors: Nicolas Dupuis, Chantal Proulx
  • Publication number: 20050266557
    Abstract: Based on previous evidence suggesting positive effects of fever on in vivo hematopoiesis, the effect of hyperthermia on the expansion and differentiation of megakaryocytes (MKs) in ex vivo cultures of CB CD34-enriched cells has now been tested. Cells were cultured at 37° C. or 39° C. for 14 days in cytokine conditions optimized for MK development, and analyzed periodically by microscopy, flow cytometry and colony assays. Compared to 37°?C., cultures maintained at 39° C. produced much more total cells (5X), MK progenitors (9X) and total MKs (7X), and showed accelerated (3-4 days) and enhanced MK maturation with increased yields of proplatelets and platelets (11.7X). The increased number of CD34+ cells and myeloid progenitors in the 39° C. cultures also suggested a general stimulatory effect of hyperthermia on the expansion of more primitive stem/progenitor cells and of cells of other lineages.
    Type: Application
    Filed: April 25, 2005
    Publication date: December 1, 2005
    Applicant: HEMA-QUEBEC
    Inventors: Chantal Proulx, Nicolas Dupuis, Real Lemieux
  • Patent number: 6472208
    Abstract: The present invention relates to a novel method for producing human natural interferon-&agr; using ex vivo expanded cord blood hematopoietic cells infected with sendaivirus, on a large scale.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: October 29, 2002
    Assignees: Héma-Québec, Canadian Blood Services
    Inventors: Réal Lemieux, Sonia Néron, Chantal Proulx